Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 44 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Desc)]
Φίλτρα: Keyword is Chemotherapy, Adjuvant  [Clear All Filters]
2009
Maniadakis, N., Dafni U., Fragoulakis V., Grimani I., Galani E., Fragkoulidi A., et al. (2009).  Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial.. Ann Oncol. 20(2), 278-85.
Pentheroudakis, G., Kalogeras K. T., Wirtz R. M., Grimani I., Zografos G., Gogas H., et al. (2009).  Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.. Breast Cancer Res Treat. 116(1), 131-43.
Iliadis, G., Selviaridis P., Kalogera-Fountzila A., Fragkoulidi A., Baltas D., Tselis N., et al. (2009).  The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models.. Strahlenther Onkol. 185(11), 743-50.
Koumarianou, A., Fountzilas G., Kosmidis P., Klouvas G., Samantas E., Kalofonos C., et al. (2009).  Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients.. J Chemother. 21(5), 573-83.
Skarlos, D. V., Timotheadou E., Galani E., Samantas E., Grimani I., Lianos E., et al. (2009).  Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic C. Oncology. 77(2), 107-12.
Pectasides, D., Dafni U., Bafaloukos D., Skarlos D., Polyzos A., Tsoutsos D., et al. (2009).  Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma.. J Clin Oncol. 27(6), 939-44.
Kostopoulos, I., Karavasilis V., Karina M., Bobos M., Xiros N., Pentheroudakis G., et al. (2009).  Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.. BMC Cancer. 9, 339.
Maniadakis, N., Fragoulakis V., Pectasides D., & Fountzilas G. (2009).  XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis.. Curr Med Res Opin. 25(3), 797-805.
2012
Fountzilas, G., Dafni U., Bobos M., Batistatou A., Kotoula V., Trihia H., et al. (2012).  Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.. PLoS One. 7(6), e37946.
Fountzilas, G., Valavanis C., Kotoula V., Eleftheraki A. G., Kalogeras K. T., Tzaida O., et al. (2012).  HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.. J Transl Med. 10, 10.
Gogas, H., Dafni U., Karina M., Papadimitriou C., Batistatou A., Bobos M., et al. (2012).  Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.. Breast Cancer Res Treat. 132(2), 609-19.
Tsolakidis, D., Papanikolaou A., Ktenidis K., & Pervana S. (2012).  Primary ovarian small cell carcinoma of pulmonary type with enlarged paraaortic lymph node masses: a case report and review of the literature.. Eur J Gynaecol Oncol. 33(3), 312-5.
Skarlos, P., Christodoulou C., Kalogeras K. T., Eleftheraki A. G., Bobos M., Batistatou A., et al. (2012).  Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.. Cancer Chemother Pharmacol. 69(2), 533-46.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.